Ignite Creation Date:
2025-12-24 @ 2:41 PM
Ignite Modification Date:
2025-12-26 @ 7:20 AM
Study NCT ID:
NCT00716859
Status:
COMPLETED
Last Update Posted:
2021-02-03
First Post:
2008-07-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma.
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-07
Start Date Type:
None
Primary Completion Date:
2009-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-11
Completion Date Type:
ACTUAL
First Submit Date:
2008-07-14
First Submit QC Date:
None
Study First Post Date:
2008-07-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-11-01
Results First Submit QC Date:
None
Results First Post Date:
2010-12-02
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-01
Last Update Post Date:
2021-02-03
Last Update Post Date Type:
ACTUAL